1. Switzerland Stocks

  2. •

    Healthcare

  3. •

    Medical - Specialties
Sonova Holding AG

Sonova Holding AG

0QPY.IL
Sonova Holding AGGB flagInternational Order Book
243.60
CHF
+4.10
- -
14.47BMarket Cap
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
2026 Y
Revenue per Share
28.88
30.14
31.21
36.43
40.24
42.19
45.62
41.32
54.02
62.07
60.82
60.62
- -
Basic EPS, GAAP
5.04
5.33
5.08
5.31
6.08
6.93
7.56
9.23
10.42
10.75
10.08
9.07
- -
Free Cash Flow per Basic Share
4.68
5.49
5.2
6.45
7.96
8.14
11.18
10.72
13.4
10.45
10.48
11.05
- -
Dividend per Share
1.59
1.89
2.05
2.09
2.29
2.59
2.92
- -
3.24
4.44
4.6
4.3
- -
Book Value per Share
25.81
27.5
28.58
32.02
37.28
36.33
32
43.59
39.46
37.12
41.44
44.7
44
Tangible Book Value per Share
8.63
9.32
8.09
-3.26
-0.22
-1.69
-6.51
5.17
-8.81
-14.19
-9.53
-5.37
-0.12
Basic Weighted Avg Shares
68
68
66
66
66
66
64
63
62
60
60
60
- -
Sales/Revenue/Turnover
1,951
2,035
2,072
2,396
2,646
2,763
2,917
2,602
3,364
3,738
3,627
3,613
3,606
Operating Margin (%)
20.71
21.08
19.05
17.69
18.05
19.39
17.48
19.03
22.6
19.98
18.47
19.92
18.74
Depreciation Expense
83
85
89
147
135
128
200
223
211
240
246
233
260
Net Income, GAAP
341
360
337
349
400
454
483
581
649
648
601
540
431
Effective Tax Rate (%)
11.96
12.37
12.9
14.65
14.93
13.1
2.57
2.53
8.86
8.02
5.84
17.45
14.91
Profit Margin (%)
17.47
17.69
16.27
14.58
15.12
16.43
16.57
22.33
19.29
17.32
16.57
14.96
11.94
Working Capital
507
569
499
532
582
282
118
1,368
154
409
514
411
895
LT Debt
- -
- -
- -
759
609
360
767
1,410
1,080
1,736
1,715
1,328
1,525
Total Equity
1,774
1,872
1,906
2,131
2,475
2,376
2,029
2,772
2,433
2,231
2,491
2,685
2,636
Return on Invested Capital (%)
18.75
19.59
17.53
14.58
12.85
14.48
15.83
12.23
15.81
16.65
14.57
13.11
12.73
Return on Capital (%)
18.31
19.01
17.44
14.33
12.88
14.47
15.92
15.44
15.35
16.53
14.86
12.74
10.15
Return on Common Equity (%)
20.3
20.06
18.09
17.5
17.55
18.9
22.14
24.42
25.16
28.01
25.67
21.05
16.32

Capital Structure

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
4.3%
-0.59%
-1.81%
Free Cash Flow
7.62%
-0.08%
-4.07%
Net Income, GAAP
3.22%
-5.22%
-20.33%
Sales/Revenue/Turnover
6.21%
7.37%
-0.19%
Total Cash Common Dividend
10,066.44%
20,146.2%
2.38%

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
3,627
2025
- -
- -
- -
- -
3,613
2026
- -
- -
- -
- -
3,606

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
10.08
2025
- -
- -
- -
- -
9.07
2026
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
4.6
2025
- -
- -
- -
- -
4.3
2026
- -
- -
- -
- -
- -

Company Description

APIChatGPT
CEO
Arnd Kaldowski
Full Time Employees
18,447
Sector
Healthcare
Industry
Medical - Specialties
Address
Laubisrütistrasse 28 Stäfa ZH Switzerland 8712
IPO Date
Mar 7, 2014
Website
sonova.com
Similar Companies
Virtuoso Optoelectronics Limit (VOEPL.BO)
T&R Biofab Co., Ltd. (246710.KQ)
WORK Medical Technology Group Ltd. Class A (WOK)
Coloplast A/S (CLPBF)
Shoulder Innovations, Inc. (SI)
Zhejiang Orient Gene Biotech Co., Ltd (688298.SS)
Business
Sonova Holding AG, a leading provider of innovative hearing care solutions, engages in the design, manufacture, distribution, and sale of hearing instruments and related services. Main products and services include hearing aids across disposable, reusable, and premium lines; cochlear implant systems; bone-anchored and wireless accessories; hearing protection and patient care devices; professional diagnostic and fitting software; and aftercare services such as fitting, repairs, and remote care solutions. The company operates through core brands and product families in hearing health, with professional channels serving audiology clinics, hearing care professionals, and end customers. Latest major company changes include strategic partnerships and alliances in audiology technology, expansion of direct-to-consumer and professional channels, acquisitions and investments in innovative hearing solutions and related accessories, and launches of new product generations and software platforms. The company reports recent reorganizations and operational enhancements to support global distribution, R&D, and digital health initiatives, along with geographic expansion activities. Industry and business segments focus on hearing care and optically linked health technologies with geographic operations spanning Europe, North America, Asia-Pacific, and other regions. Founding year is 1946 with headquarters in Staefa-Zh, Switzerland. Sonova maintains subsidiaries and brand-level operations worldwide, including affiliated entities within its global corporate structure. The company emphasizes advanced audiology products, patient-centered care, and scalable hearing care solutions for diverse customer groups, including individual consumers, clinics, and healthcare providers.